Cartesian Therapeutics
RNAC
$26.43
Share price
0.34%
Change (1 day)
2,281.08%
Change (1 year)
Categories
Cartesian Therapeutics (RNAC) - Total debt
Total debt on the balance sheet as of December 2023 : $10.95 M
According to Cartesian Therapeutics's latest financial reports the company's total debt is $10.95 M. A company’s total debt is the sum of all current and non-current debts.
Cartesian Therapeutics - Total debt on balance sheet (from 2015 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $10.95 M | -71.11% |
| 2022-12-31 | $37.92 M | 7.49% |
| 2021-12-31 | $35.28 M | -0.19% |
| 2020-12-31 | $35.34 M | 83.37% |
| 2019-12-31 | $19.27 M | -9.86% |
| 2018-12-31 | $21.38 M | 1.63% |
| 2017-12-31 | $21.04 M | 74.71% |
| 2016-12-31 | $12.04 M | 1.59% |
| 2015-12-31 | $11.85 M | 60.16% |
| 2014-12-31 | $7.4 M |